The Dutch Prolactinoma Cohort Studies: Cross-sectional Analysis of Females Focusing on the Patient's Perspective.

Authors

Victoria R van Trigt, Iris C M Pelsma, Ingrid M Zandbergen, Leontine E H Bakker, Olaf M Dekkers, Amir H Zamanipoor Najafabadi, Saskia le Cessie, M Elske van den Akker-van Marle, Madeleine L Drent, Dirk Jan Stenvers, Ingrid I L Berk-Planken, Kees van den Berge, Merel van Andel, Kitty Kapiteijn, Sanne G H A Swinnen, Aline M E Stades, Richard A Feelders, Annenienke C van de Ven, Jantien Hoogmoed, Melanie M van der Klauw, Alberto M Pereira, Cornelie D Andela, Marco J T Verstegen, Wouter R van Furth, Nienke R Biermasz, Dutch Prolactinoma Study Group

Published in

The Journal of clinical endocrinology and metabolism. Aug 13, 2026. Epub Aug 13, 2026.

Abstract

To assess the results of patient-reported outcome measures (PROMs) in a national cohort of females with a prolactinoma by disease activity.
Females with prolactinoma included in the PRolaCT or ProlaC study were assessed cross-sectionally, comparing patients with active (prolactin above upper limit of normal (ULN)) and controlled (prolactinFour hundred and fifty females with a prolactinoma were included (active: n=223, controlled: n=227), most were treated with dopamine agonists (DAs) (97.0%). Fatigue was the most prevalent symptom in both patients with active and controlled disease (92.6%, and 86.4%, respectively) followed by concentration problems (79.0%, and 64.5%, respectively) (modified PRO-CTCAE, LBNQ-Pituitary). Anxiety and depressive symptoms were worse in patients with active compared to controlled disease (HADS-Anxiety: 8.0 ± 4.5 vs 6.4 ± 4.5 p<0.001. HADS-Depression: 6.4 ± 5.0 vs 4.7 ± 4.4 p<0.001). Disease burden was higher in patients with active compared to controlled disease (LBNQ-Pituitary: Total Bother 24.4 ± 22.9 vs 16.4 ± 17.9 (p<0.001).
Females with a prolactinoma were most affected by fatigue and cognitive complaints. Although patients with active disease perceived more burden than patients with controlled disease, symptoms including fatigue, psychological and cognitive complaints were prevalent despite disease control. Therefore, improvement of treatment and rehabilitation strategies is needed.

PMID:
42592847
Bibliographic data and abstract were imported from PubMed on 13 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.